Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is an active Phase 2 trial registration with no reported results; it describes a planned study of a combination approach in triple-negative breast cancer with a metabolic biomarker as primary outcome.